BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 828887)

  • 1. [Antibody response in subjects with meningococal disease and in healthy carriers of Neisseria meningitidis].
    Natoli D; Tringali G; Puma G; Castellini S; Chiarini A
    G Batteriol Virol Immunol; 1976; 69(1-6):64-70. PubMed ID: 828887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human antibody responses to the meningococcal factor H binding protein (LP2086) during invasive disease, colonization and carriage.
    Ala'aldeen DA; Flint M; Oldfield NJ; Omer SA; McNeil LK; Jiang Q; Murphy E; Giardina PC; Novikova EG; Dodge-Scully IL; Bayliss CD; Turner DP; Neal KR; Hoiseth SK; Jansen KU; Anderson AS
    Vaccine; 2010 Nov; 28(48):7667-75. PubMed ID: 20875489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease.
    Litt DJ; Savino S; Beddek A; Comanducci M; Sandiford C; Stevens J; Levin M; Ison C; Pizza M; Rappuoli R; Kroll JS
    J Infect Dis; 2004 Oct; 190(8):1488-97. PubMed ID: 15378443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.
    Ceyhan M; Yildirim I; Balmer P; Riley C; Laher G; Andrews N; Borrow R; Kurt N; Turgut M; Aydogan A; Ecevit C; Uysal G; Schultze V
    Vaccine; 2007 Oct; 25(41):7233-7. PubMed ID: 17707957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on serum meningococcal antibodies in patients with meningococcal meningitis and a healthy population].
    Pang HM
    Zhonghua Yu Fang Yi Xue Za Zhi; 1988 Jul; 22(4):233-5. PubMed ID: 3146488
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic memory with no detectable bactericidal antibody response to a first dose of meningococcal serogroup C conjugate vaccine at four years.
    McVernon J; MacLennan J; Pollard AJ; Oster P; Wakefield MJ; Danzig L; Moxon ER
    Pediatr Infect Dis J; 2003 Jul; 22(7):659-61. PubMed ID: 12886896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Specific antibody response in carriers of N. meningitidis].
    Tomásik E; Kuzemenská P
    Cesk Epidemiol Mikrobiol Imunol; 1989 Jul; 38(4):221-7. PubMed ID: 2507173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum factors and polymorphonuclear leukocytes in human host defence against Neisseria meningitidis. Studies of interactions with special reference to a chemiluminometric technique.
    Fredlund H
    Scand J Infect Dis Suppl; 1993; 87():1-72. PubMed ID: 8511525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Method of obtaining meningococcal agglutinating serum of high titre and its use in the indirect immunofluorescence test].
    Okropiridze GG; Pavlov GA; Mal'tseva AN; Akopiants EIa; Balashova RR
    Lab Delo; 1977; (8):489-91. PubMed ID: 72859
    [No Abstract]   [Full Text] [Related]  

  • 10. Sero-epidemiology of Neisseria meningitidis infections in parts of Eastern Nigeria.
    Njoku-Obi AN
    J Hyg Epidemiol Microbiol Immunol; 1977; 21(2):122-7. PubMed ID: 410874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the campaign on vaccination against meningococcal disease in Galicia. Methodology, advantages and disadvantages, Study of carriers].
    Malvar Pintos A
    Rev Esp Salud Publica; 1998; 72(5):393-400. PubMed ID: 9951330
    [No Abstract]   [Full Text] [Related]  

  • 12. Age dependence of in vitro survival of meningococci in whole blood during childhood.
    Ison CA; Anwar N; Cole MJ; Pollard AJ; Morley SL; Fidler K; Sandiford C; Banks J; Kroll SJ; Levin M
    Pediatr Infect Dis J; 2003 Oct; 22(10):868-73. PubMed ID: 14551486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Group-specific A-antibodies in persons living in the foci of meningococcal infection].
    Zotova AB; Denisenko LI
    Zdravookhr Kirg; 1977; 0(6):35-9. PubMed ID: 24953
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bactericidal activity against Neisseria meningitidis serogroup C in the vaccinated and non-vaccinated population of Andlucía].
    Delgado Torralbo E; Berrón Morato S; García León J; González Enríquez J; Martinez Navarro F
    Rev Esp Salud Publica; 1998; 72(5):407-10. PubMed ID: 9951332
    [No Abstract]   [Full Text] [Related]  

  • 15. The 2001 serological survey in the Czech Republic--invasive meningococcal disease.
    Krízová P
    Cent Eur J Public Health; 2003 Dec; 11 Suppl():S62-7. PubMed ID: 15080262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bactericidal antibody after colonization with Neisseria meningitidis.
    Reller LB; MacGregor RR; Beaty HN
    J Infect Dis; 1973 Jan; 127(1):56-62. PubMed ID: 4630238
    [No Abstract]   [Full Text] [Related]  

  • 17. [Humoral immunity and resistance to acute meningococcal infections].
    Linz R; Lecocq E; Mommens M
    Pathol Biol (Paris); 1974 Mar; 22(3):201-6. PubMed ID: 4211456
    [No Abstract]   [Full Text] [Related]  

  • 18. Confirmation of invasive meningococcal disease by single point estimation of IgM antibody to outer membrane protein of Neisseria meningitidis.
    Robertson PW; Reinbott P; Duffy Y; Binotto E; Tapsall JW
    Pathology; 2001 Aug; 33(3):375-8. PubMed ID: 11523943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in England.
    Trotter C; Findlow J; Balmer P; Holland A; Barchha R; Hamer N; Andrews N; Miller E; Borrow R
    Clin Vaccine Immunol; 2007 Jul; 14(7):863-8. PubMed ID: 17494636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dynamic observation of the epidemic process in meningococcal infection in a unit].
    Perepelkin VS; Polianin VA
    Voen Med Zh; 1984 Oct; (10):35-7. PubMed ID: 6438903
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.